A growing number of U.S veterans, desperate to treat PTSD, are turning to psychedelics. They're headed to other countries, ...

Minutes joined U.S. veterans with PTSD as they attend a week-long psychedelic retreat in Mexico. Nearly a year later, most of ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms of generalized anxiety disorder (GAD) in clinical trials. However, there is ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

Kennedy Jr. was pressed to clarify his views on vaccines, abortion and public health priorities in the first of two senate ...

Robert F. Kennedy Jr. makes his first congressional appearance Wednesday as President Trump’s pick to lead HHS. Follow STAT's ...

President Donald Trump’s budget office has rescinded an order freezing spending on federal grants, less than two days after it sparked widespread confusion and legal challenges across the country, acc ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...